Gastric ulcer in a child treated with deferasirox

Pharm World Sci. 2010 Apr;32(2):112-3. doi: 10.1007/s11096-009-9357-1. Epub 2010 Jan 9.

Abstract

We present a patient with thalassemia major who developed a gastric ulcer, probably related to the use of deferasirox. Although gastric ulcer is mentioned as infrequent adverse event in the scientific product information of deferasirox, in our current knowledge, this is the first case-report on this adverse drug reaction. The severity of this event justifies the reporting of this case.

Publication types

  • Case Reports

MeSH terms

  • Benzoates / adverse effects*
  • Benzoates / therapeutic use
  • Child
  • Deferasirox
  • Female
  • Humans
  • Iron Chelating Agents / adverse effects*
  • Iron Chelating Agents / therapeutic use
  • Stomach Ulcer / chemically induced*
  • Triazoles / adverse effects*
  • Triazoles / therapeutic use
  • beta-Thalassemia / drug therapy

Substances

  • Benzoates
  • Iron Chelating Agents
  • Triazoles
  • Deferasirox